生物科技LOF(161122)资产负债表
|
2025-06-30 |
2024-12-31 |
2024-06-30 |
2023-12-31 |
资产 |
银行存款 |
- |
- |
- |
- |
结算备付金 |
75,864.90 |
110,220.33 |
50,588.34 |
90,794.74 |
存出保证金 |
32,737.73 |
35,434.27 |
22,902.09 |
41,526.94 |
交易性金融资产 |
763,343,948.24 |
675,816,068.74 |
651,334,021.77 |
873,971,862.50 |
其中:股票投资 |
763,343,948.24 |
675,816,068.74 |
631,072,032.59 |
853,773,801.99 |
债券投资 |
- |
- |
20,261,989.18 |
20,198,060.51 |
资产支持证券投资 |
- |
- |
- |
- |
衍生金融资产 |
- |
- |
- |
- |
买入返售金融资产 |
- |
- |
- |
- |
应收证券清算款 |
1,142,873.02 |
- |
5,864.08 |
1,165,284.19 |
应收利息 |
- |
- |
- |
- |
应收股利 |
- |
- |
3,010.00 |
- |
应收申购款 |
959,982.13 |
1,325,697.44 |
1,142,331.10 |
1,661,316.53 |
其他资产 |
- |
- |
17,420.81 |
92,326.72 |
资产总计 |
812,594,766.04 |
718,174,157.22 |
669,406,959.98 |
904,107,513.72 |
负 债 |
短期借款 |
- |
- |
- |
- |
交易性金融负债 |
- |
- |
- |
- |
衍生金融负债 |
- |
- |
- |
- |
卖出回购金融资产款 |
- |
- |
- |
- |
应付证券清算款 |
- |
- |
- |
- |
应付赎回款 |
8,270,266.43 |
2,620,635.45 |
1,462,144.49 |
1,668,857.45 |
应付管理人报酬 |
328,089.57 |
319,520.23 |
285,679.57 |
385,107.61 |
应付托管费 |
65,617.90 |
63,904.05 |
57,135.91 |
77,021.51 |
应付销售服务费 |
25,428.85 |
23,800.57 |
19,360.51 |
23,552.35 |
应付交易费用 |
- |
- |
- |
- |
应交税费 |
- |
- |
4,646.07 |
10,754.13 |
应付利息 |
- |
- |
- |
- |
应付利润 |
- |
- |
- |
- |
其他负债 |
113,398.04 |
248,355.63 |
165,454.34 |
290,768.61 |
负债合计 |
8,802,800.79 |
3,276,215.93 |
1,994,420.89 |
2,456,061.66 |
所有者权益 |
实收基金 |
1,018,092,811.43 |
995,190,875.59 |
1,014,325,118.16 |
995,108,037.57 |
未分配利润 |
-214,300,846.18 |
-280,292,934.30 |
-346,912,579.07 |
-93,456,585.51 |
所有者权益合计 |
803,791,965.25 |
714,897,941.29 |
667,412,539.09 |
901,651,452.06 |
负债及所有者权益总计 |
812,594,766.04 |
718,174,157.22 |
669,406,959.98 |
904,107,513.72 |
欢迎访问证券之星!请点此与我们联系 版权所有: Copyright © 1996-年